What is cardiometabolic risk?

Cardiometabolic risk is not a single condition. It is a cluster of interconnected metabolic and cardiovascular problems that develop together, quietly, over years - and dramatically increase the likelihood of heart attack, stroke, type 2 diabetes, and early death.

The cluster includes high blood pressure, elevated blood sugar, abnormal cholesterol and triglyceride levels, excess abdominal fat, and insulin resistance. None of these are minor issues in isolation. Together, they are exponentially more dangerous. And together, they are increasingly common.

The numbers are difficult to overstate. Cardiovascular disease remains the leading cause of death in Canada. Type 2 diabetes affects more than three million Canadians, with hundreds of thousands more undiagnosed. Insulin resistance, which is the engine driving much of this, is estimated to affect the majority of Canadian adults to some degree.

This is the defining chronic disease crisis of our time.

What's actually driving it

The conventional focus has been on individual risk factors - high cholesterol, high blood pressure, high blood sugar - treated as separate problems with separate medications. That approach has not reversed the trend.

What the evidence increasingly points to is a common upstream driver: insulin resistance. When cells stop responding properly to insulin, the body compensates by producing more of it. Chronically elevated insulin disrupts virtually every metabolic system - driving fat storage, raising blood pressure, promoting inflammation, and accelerating cardiovascular disease.

Insulin resistance doesn't announce itself. Standard bloodwork often misses it. By the time a diagnosis appears - pre-diabetes, metabolic syndrome, hypertension - the process has typically been underway for years.

The factors that drive it are well established: ultra-processed food, excess refined carbohydrates, chronic stress, poor sleep, and sedentary behaviour.

They are also, to a meaningful degree, addressable.

What the standard model often misses

The standard clinical model is designed to detect and manage established disease - not identify metabolic dysfunction before it becomes diagnosable.

A routine physical checks fasting glucose, total cholesterol, and blood pressure. It rarely assesses insulin levels directly, measures advanced lipid particle size, or evaluates inflammatory markers. It tells you whether you've crossed a threshold. It doesn't tell you how close you are, or which direction you're moving.

For many Canadians, the first signal that something is wrong is a serious one. The years of metabolic drift that preceded it went undetected because no one was looking in the right way.

This is the gap that comprehensive cardiometabolic assessment is designed to fill.

What a comprehensive assessment looks at

A cardiometabolic assessment goes beyond standard bloodwork to build a full picture of how your cardiovascular and metabolic systems are functioning - and where risk is accumulating.

This includes direct assessment of insulin sensitivity and resistance, advanced lipid profiling beyond total cholesterol, inflammatory markers linked to cardiovascular risk, blood sugar regulation across time rather than a single fasting snapshot, body composition with a focus on visceral fat, and blood pressure patterns under varying conditions.



The goal is to identify the trajectory early - when intervention is most effective and the changes required are the least disruptive.

What can be done

Cardiometabolic risk is not a fixed condition. It is a direction. And direction can change.

The evidence base for lifestyle intervention in cardiometabolic risk is among the strongest in medicine:

• Reducing refined carbohydrates and ultra-processed food directly lowers insulin levels and improves metabolic function.
• Structured exercise - particularly aerobic training combined with resistance work - improves insulin sensitivity, reduces visceral fat, and lowers cardiovascular risk markers independently of weight loss.
• Sleep quality has a direct and measurable impact on glucose regulation and insulin sensitivity.
• Chronic stress elevates cortisol, which drives insulin resistance; stress reduction is a clinical priority.

Where lifestyle intervention alone is insufficient, or where risk is already elevated, medical management has an important role. The key is knowing which interventions are appropriate for your specific risk profile - and that requires knowing what your risk profile actually is.

A supervised, evidence-informed approach built around your individual assessment will always produce better outcomes than generalized advice.

At RCM Health

Cardiometabolic risk assessment is part of how we build Wellness and Prevention Action Plans for clients who want to address root causes before they become diagnoses.

We begin with a comprehensive review of your health history, medications, lifestyle, and goals - and develop an intervention plan coordinated with your broader care team.



The earlier the picture is clear, the more options you have.

To learn more about RCM Health services:



647-350-5500

info@rcmhealth.ca



Raymond Rupert | CEO

RCM Health Consultancy Inc.

www.rcmhealth.ca